$CERS stock has now fallen 8% today, according to our price data from Polygon. There has been approximately $1,299,867 of trading volume.
Here is what we see in our data on $CERS (you can track the company live on Quiver's $CERS stock page):
$CERS Insider Trading Activity
$CERS insiders have traded $CERS stock on the open market 13 times in the past 6 months. Of those trades, 0 have been purchases and 13 have been sales.
Here’s a breakdown of recent trading of $CERS stock by insiders over the last 6 months:
- WILLIAM MARINER GREENMAN (President and CEO) has made 0 purchases and 2 sales selling 525,944 shares for an estimated $898,826.
- RICHARD J BENJAMIN (Chief Medical Officer) has made 0 purchases and 4 sales selling 227,634 shares for an estimated $419,541.
- VIVEK K JAYARAMAN (Chief Operating Officer) has made 0 purchases and 3 sales selling 215,961 shares for an estimated $392,145.
- KEVIN DENNIS GREEN (Chief Financial Officer) has made 0 purchases and 3 sales selling 210,565 shares for an estimated $381,012.
- CHRYSTAL JENSEN (Chief Legal Officer) sold 30,845 shares for an estimated $61,859
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$CERS Hedge Fund Activity
We have seen 85 institutional investors add shares of $CERS stock to their portfolio, and 78 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- SOLEUS CAPITAL MANAGEMENT, L.P. added 6,753,700 shares (+168.8%) to their portfolio in Q1 2026, for an estimated $12,291,734
- MORGAN STANLEY removed 1,114,173 shares (-57.4%) from their portfolio in Q1 2026, for an estimated $2,027,794
- DRIEHAUS CAPITAL MANAGEMENT LLC added 961,606 shares (+inf%) to their portfolio in Q1 2026, for an estimated $1,750,122
- UBS GROUP AG added 956,851 shares (+83.8%) to their portfolio in Q1 2026, for an estimated $1,741,468
- CITADEL ADVISORS LLC removed 945,020 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $1,719,936
- TWO SIGMA INVESTMENTS, LP added 887,911 shares (+47.8%) to their portfolio in Q1 2026, for an estimated $1,615,998
- ARK INVESTMENT MANAGEMENT LLC removed 649,984 shares (-3.4%) from their portfolio in Q4 2025, for an estimated $1,338,967
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$CERS Government Contracts
We have seen $757,061 of award payments to $CERS over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- 25-007944 INTERCEPT PLATELET PROCESSING SETS: $115,699
- INTERCEPT PLATELET PROCESSING KITS: $77,888
- INT2540B DROP SHIPMENT FOR PLATELET PROCESSING: $71,520
- INTERCEPT PLATELET PROCESSING SET AND SERVICE MAINTENANCE: $64,626
- INTERCEPT PLATELET SET PN INT2140B: $44,528
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard. You can access data on government contracts through the Quiver Quantitative API government contracts endpoint.
$CERS Analyst Ratings
Wall Street analysts have issued reports on $CERS in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- BTIG issued a "Buy" rating on 05/01/2026
To track analyst ratings and price targets for $CERS, check out Quiver Quantitative's $CERS forecast page.
You can track data on $CERS on Quiver Quantitative.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
